Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression
Authors
Keywords
Non-alcoholic fatty liver disease (NAFLD), De novo lipogenesis (DNL), Lipid remodelling, Western diet, Carbon tetrachloride (CCl, 4, ), Liver regeneration
Journal
Molecular Metabolism
Volume 48, Issue -, Pages 101210
Publisher
Elsevier BV
Online
2021-03-19
DOI
10.1016/j.molmet.2021.101210
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adipose tissue-liver cross talk in the control of whole-body metabolism: implications in non-alcoholic fatty liver disease
- (2020) Vian Azzu et al. GASTROENTEROLOGY
- Lipid remodelling in hepatocyte proliferation and hepatocellular carcinoma
- (2020) Zoe Hall et al. HEPATOLOGY
- Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity
- (2020) Marion Régnier et al. Scientific Reports
- Probing the Global Cellular Responses to Lipotoxicity Caused by Saturated Fatty Acids
- (2019) Manuele Piccolis et al. MOLECULAR CELL
- Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues
- (2019) Doralicia Casares et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Adaptive immunity: an emerging player in the progression of NAFLD
- (2019) Salvatore Sutti et al. Nature Reviews Gastroenterology & Hepatology
- Macrophages and lipid metabolism
- (2018) Anneleen Remmerie et al. CELLULAR IMMUNOLOGY
- Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis
- (2018) Eric J. Lawitz et al. Clinical Gastroenterology and Hepatology
- Saturated Fat Is More Metabolically Harmful for the Human Liver Than Unsaturated Fat or Simple Sugars
- (2018) Panu K. Luukkonen et al. DIABETES CARE
- Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
- (2018) Oliver Krenkel et al. HEPATOLOGY
- Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice
- (2018) Albert G. Linden et al. JOURNAL OF LIPID RESEARCH
- Triggering and resolution of inflammation in NASH
- (2018) Susanne Schuster et al. Nature Reviews Gastroenterology & Hepatology
- The Role of Lipid Metabolism in T Lymphocyte Differentiation and Survival
- (2018) Duncan Howie et al. Frontiers in Immunology
- Burden of Illness and Economic Model for Patients with Non-Alcoholic Steatohepatitis (NASH) in the United States
- (2018) Zobair M. Younossi et al. HEPATOLOGY
- Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease
- (2017) Zoe Hall et al. HEPATOLOGY
- The epidemiology of non-alcoholic fatty liver disease
- (2017) Stefano Bellentani LIVER INTERNATIONAL
- Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients
- (2017) Franck Chiappini et al. Scientific Reports
- Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
- (2016) Timothy Hardy et al. Annual Review of Pathology-Mechanisms of Disease
- A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
- (2016) Amon Asgharpour et al. JOURNAL OF HEPATOLOGY
- Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
- (2016) Panu K. Luukkonen et al. JOURNAL OF HEPATOLOGY
- Role of lipids in the metabolism and activation of immune cells
- (2016) Merla J. Hubler et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Biomarkers of NAFLD progression: a lipidomics approach to an epidemic
- (2015) D. Lee Gorden et al. JOURNAL OF LIPID RESEARCH
- Fatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
- (2015) Michael Allison et al. SEMINARS IN LIVER DISEASE
- Pharmacological inhibition of the chemokine C-C motif chemokine ligand 2 (monocyte chemoattractant protein 1) accelerates liver fibrosis regression by suppressing Ly-6C+macrophage infiltration in mice
- (2014) Christer Baeck et al. HEPATOLOGY
- FELASA recommendations for the health monitoring of mouse, rat, hamster, guinea pig and rabbit colonies in breeding and experimental units
- (2014) et al. LABORATORY ANIMALS
- Adaptive Changes of the Insig1/SREBP1/SCD1 Set Point Help Adipose Tissue to Cope With Increased Storage Demands of Obesity
- (2013) S. Carobbio et al. DIABETES
- Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
- (2013) Jennifer E. Lambert et al. GASTROENTEROLOGY
- Hepatic-specific activation of peroxisome proliferator-activated receptor γ coactivator-1β protects against steatohepatitis
- (2013) Elena Bellafante et al. HEPATOLOGY
- Free cholesterol accumulation in hepatic stellate cells: Mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice
- (2013) Kengo Tomita et al. HEPATOLOGY
- Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
- (2013) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients
- (2012) Pierre Bedossa et al. HEPATOLOGY
- The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
- (2012) Fadila Benhamed et al. JOURNAL OF CLINICAL INVESTIGATION
- Nuclear receptors in regenerating liver and hepatocellular carcinoma
- (2012) Michele Vacca et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression of murine liver fibrosis
- (2012) P. Ramachandran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SREBP-2: A link between insulin resistance, hepatic cholesterol, and inflammation in NASH
- (2011) Derrick M Van Rooyen et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- No association between polymorphisms in the INSIG1 gene and the risk of type 2 diabetes and related traits
- (2010) Magdalena Szopa et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- An allostatic control of membrane lipid composition by SREBP1
- (2010) Rachel M. Hagen et al. FEBS LETTERS
- The plasma lipidomic signature of nonalcoholic steatohepatitis
- (2009) Puneet Puri et al. HEPATOLOGY
- Hepatic Lipid Partitioning and Liver Damage in Nonalcoholic Fatty Liver Disease
- (2009) Zheng Zheng Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
- (2009) Curtis K. Argo et al. JOURNAL OF HEPATOLOGY
- Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH
- (2009) Francisco Caballero et al. JOURNAL OF HEPATOLOGY
- INSIG1influences obesity-related hypertriglyceridemia in humans
- (2009) E. M. Smith et al. JOURNAL OF LIPID RESEARCH
- Genome-wide analysis of SREBP-1 binding in mouse liver chromatin reveals a preference for promoter proximal binding to a new motif
- (2009) Y.-K. Seo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Increased overall mortality and liver-related mortality in non-alcoholic fatty liver disease
- (2008) Janus P. Ong et al. JOURNAL OF HEPATOLOGY
- Liver gene expression analysis reveals endoplasmic reticulum stress and metabolic dysfunction in SCD1-deficient mice fed a very low-fat diet
- (2008) Matthew T. Flowers et al. PHYSIOLOGICAL GENOMICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now